Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial
- DOI
- 10.1016/j.langlo.2026.104083
- Published
- 2026-11
- Container
- The Lancet Global Health
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.langlo.2026.104083,
title = {Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial},
author = {Arun K Sharma and Visalakshi Jeyaseelan and Sudha Basnet and Shreejana Dangol and Dhruba Shrestha and Ganendra B Raya and Bernardo A Mainou and Kathryn A V Jones and Laxman P Shrestha and Ondrej Mach and Harish Verma},
year = {2026},
journal = {The Lancet Global Health},
doi = {10.1016/j.langlo.2026.104083},
url = {https://doi.org/10.1016/j.langlo.2026.104083}
}RIS
TY - JOUR TI - Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial AU - Arun K Sharma AU - Visalakshi Jeyaseelan AU - Sudha Basnet AU - Shreejana Dangol AU - Dhruba Shrestha AU - Ganendra B Raya AU - Bernardo A Mainou AU - Kathryn A V Jones AU - Laxman P Shrestha AU - Ondrej Mach AU - Harish Verma PY - 2026 JO - The Lancet Global Health DO - 10.1016/j.langlo.2026.104083 UR - https://doi.org/10.1016/j.langlo.2026.104083 ER -
APA
Sharma, A. K., Jeyaseelan, V., Basnet, S., Dangol, S., Shrestha, D., Raya, G. B., Mainou, B. A., Jones, K. A. V., Shrestha, L. P., Mach, O., & Verma, H. (2026). Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial. The Lancet Global Health. https://doi.org/10.1016/j.langlo.2026.104083
Source records
- crossref · retrieved 2026-11-09T10:56:19.165Z